CLINICAL_TRIALS
trial_result
· 2021-03-15
Clinical Trial Update: A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction. [Phase 2]
Summary
Phase 2b trial update for CSL112 in patients after acute myocardial infarction has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CSL Behring | Conditions: Acute Myocardial Infarction | Phase 2 | Status: COMPLETED | Results posted: 2021-03-15